MARC details
000 -LEADER |
fixed length control field |
04005 a2200241 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
SA-DaMAC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20211021020012.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
210104b20202021 aaaa r 000 0 eng c |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780857113696 |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
Source |
0857113690 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
SA-DaMAC |
Language of cataloging |
ENG |
Transcribing agency |
SA-DaMAC |
050 04 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS125 |
Item number |
.J65 2020 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1341 |
245 00 - TITLE STATEMENT |
Title |
BNF 80 (British National Formulary) September 2020-March 2021 \ |
Statement of responsibility, etc. |
Joint Formulary Committee |
250 ## - EDITION STATEMENT |
Edition statement |
80th Edition |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc. |
London : |
Name of publisher, distributor, etc. |
Pharmaceutical Press, |
Date of publication, distribution, etc. |
2020. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1768 pages. |
500 ## - GENERAL NOTE |
General note |
Description based upon print version of record.<br/>Immune system disorders and transplantation. |
505 ## - FORMATTED CONTENTS NOTE |
Formatted contents note |
00 BNF 80 Front Cover --<br/>01 BNF IFC --<br/>01a BNF Insert --<br/>02 BNF Prelims --<br/>Preface --<br/>Contents --<br/>General Information --<br/>Acknowledgements --<br/>BNF Staff --<br/>Joint Formulary Committee --<br/>Dental Advisory Group --<br/>Nurse Prescribers&rsquo --<br/>Advisory Group --<br/>How BNF Publications are constructed --<br/>How to use BNF Publications in print --<br/>Changes --<br/>03 BNF Main Chapters --<br/>Guidance on prescribing --<br/>Prescription writing --<br/>Emergency supply of medicines --<br/>Controlled drugs and drug dependence --<br/>Adverse reactions to drugs --<br/>Guidance on intravenous infusions --<br/>Medicines optimisation Antimicrobial stewardship --<br/>Prescribing in children --<br/>Prescribing in hepatic impairment --<br/>Prescribing in renal impairment --<br/>Prescribing in pregnancy --<br/>Prescribing in breast-feeding --<br/>Prescribing in palliative care --<br/>Prescribing in the elderly --<br/>Drugs and sport --<br/>Prescribing in dental practice --<br/>Chapter 1 Gastro-intestinal system --<br/>Outline placeholder --<br/>Chronic bowel disorders --<br/>Constipation and bowel cleansing --<br/>Diarrhoea --<br/>Disorders of gastric acid and ulceration --<br/>Food allergy --<br/>Gastro-intestinal smooth muscle spasm --<br/>Liver disorders and related conditions --<br/>Obesity Rectal and anal disorders --<br/>Reduced exocrine secretions --<br/>Stoma care --<br/>Chapter 2 Cardiovascular system --<br/>Outline placeholder --<br/>Arrhythmias --<br/>Bleeding disorders --<br/>Blood clots --<br/>Blood pressure conditions --<br/>Cardiovascular risk assessment and prevention --<br/>Heart failure --<br/>Hyperlipidaemia --<br/>Myocardial ischaemia --<br/>Oedema --<br/>Vascular disease --<br/>Chapter 3 Respiratory system --<br/>Outline placeholder --<br/>Airways disease, obstructive --<br/>Allergic conditions --<br/>Conditions affecting sputum viscosity --<br/>Cough and congestion --<br/>Idiopathic pulmonary fibrosis Respiratory depression, respiratory distress syndrome and apnoea --<br/>Chapter 4 Nervous system --<br/>Outline placeholder --<br/>Dementia --<br/>Epilepsy and other seizure disorders --<br/>Mental health disorders --<br/>Movement disorders --<br/>Nausea and labyrinth disorders --<br/>Pain --<br/>Sleep disorders --<br/>Substance dependence --<br/>Chapter 5 Infection --<br/>Outline placeholder --<br/>Amoebic infection --<br/>Bacterial infection --<br/>Fungal infection --<br/>Helminth infection --<br/>Protozoal infection --<br/>Viral infection --<br/>Chapter 6 Endocrine system --<br/>Outline placeholder --<br/>Antidiuretic hormone disorders --<br/>Corticosteroid responsive conditions Diabetes mellitus and hypoglycaemia --<br/>Disorders of bone metabolism --<br/>Dopamine responsive conditions --<br/>Gonadotrophin responsive conditions --<br/>Hypothalamic and anterior pituitary hormone related disorders --<br/>Sex hormone responsive conditions --<br/>Thyroid disorders --<br/>Chapter 7 Genito-urinary system --<br/>Outline placeholder --<br/>Bladder and urinary disorders --<br/>Bladder instillations and urological surgery --<br/>Contraception --<br/>Erectile and ejaculatory conditions --<br/>Obstetrics --<br/>Vaginal and vulval conditions --<br/>Chapter 8 Immune system and malignant disease --<br/>Immune system |
520 ## - SUMMARY, ETC. |
Summary, etc. |
The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care. The new edition (BNF 80) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines. |
710 1# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Joint Formulary Committee |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Library of Congress Classification |
Koha item type |
Books |
Koha issues (borrowed), all copies |
2 |